참고문헌
- Carpenter, G. 1987. Receptors for epidermal growth factor and other polypeptide mitogens. Annu. Rev. Biochem. 56:881-914. https://doi.org/10.1146/annurev.bi.56.070187.004313
- Yarden, Y., and M. X. Sliwkowski. 2001. Untangling the ErbB signalling network. Nat. Rev. Mol. Cell Biol. 2: 127-137. https://doi.org/10.1038/35052073
- Laskin, J. J., and A. B. Sandler. 2004. Epidermal growth factor receptor: a promising target in solid tumours. CancerTreat. Rev. 30: 1-17.
- Herbst, R. S., and D. M. Shin. 2002. Monoclonal antibodies to target epidermal growth factor receptor-positive tumors: a new paradigm for cancer therapy. Cancer 94: 1593-1611. https://doi.org/10.1002/cncr.10372
- Capdevila, J., E. Elez, T. Macarulla, F. J. Ramos, M. Ruiz-Echarri, and J. Tabernero. 2009. Anti-epidermal growth factor receptor monoclonal antibodies in cancer treatment. Cancer Treat. Rev. 35: 354-363. https://doi.org/10.1016/j.ctrv.2009.02.001
- Brabender, J., K. D. Danenberg, R. Metzger, P. M. Schneider, J. Park, D. Salonga, A. H. Hölscher, and P. V. Danenberg. 2001. Epidermal growth factor receptor and HER2-neu mRNA expression in non-small cell lung cancer Is correlated with survival. Clin. Cancer Res. 7: 1850-1855.
- Baselga, J. 2002. Targeting the epidermal growth factor receptor with tyrosine kinase inhibitors: small molecules, big hopes. J. Clin. Oncol. 20: 2217-2219. https://doi.org/10.1200/JCO.2002.20.9.2217
- Thomas, S. M., and J. R. Grandis. 2004. Pharmacokinetic and pharmacodynamic properties of EGFR inhibitors under clinical investigation. Cancer Treat. Rev. 30: 255-268. https://doi.org/10.1016/j.ctrv.2003.10.003
- Herbst, R. S. 2004. Review of epidermal growth factor receptor biology. Int. J. Radiat. Oncol. Biol. Phys. 59(2 Suppl):21-26. https://doi.org/10.1016/j.ijrobp.2003.10.027
- Chang, K. H., M. S. Kim, G. W. Hong, Y. N. Shin, and S. H. Kim. 2012. Conversion of a murine monoclonal antibody A13 targeting epidermal growth factor receptor to a human monoclonal antibody by guided selection. Exp. Mol. Med.44: 52-59. https://doi.org/10.3858/emm.2012.44.1.005
- Kim, S. H., and S. Y. Park. 2002. Selection and characterization of human antibodies against hepatitis B virus surface antigen (HBsAg) by phage-display. Hybrid. Hybridomics. 21:385-392. https://doi.org/10.1089/153685902761022742
- Kim, S. H., J. H. Chun, and S. Y. Park. 2001. Characterization of monoclonal antibodies against carcinoembryonic antigen (CEA) and expression in E. coli. Hybridoma. 20: 265-272. https://doi.org/10.1089/027245701753179857
- Kim, S. H., S. H. Song, Y. J. Kim, and S. Y. Park. 2001. Expression and characterization of a recombinant Fab fragment derived from an anti-human alpha-fetoprotein monoclonal antibody. Mol. Cells. 11: 158-163.
- Shin, Y. W., K. H. Ryoo, K. W. Hong, K. H. Chang, J. S. Choi, M. So, P. K. Kim, J. Y. Park, K. T. Bong, and S. H. Kim. 2007. Human monoclonal antibody against Hepatitis B virus surface antigen (HBsAg). Antiviral Res. 75: 113-120. https://doi.org/10.1016/j.antiviral.2007.01.005
- Urlaub, G., P. J. Mitchell, E. Kas, L. A. Chasin, V. L. Funanage, T. T. Myoda, and J. Hamlin. 1986. Effect of gamma rays at the dihydrofolate reductase locus: deletions and inversions. Somat. Cell Mol. Genet. 12: 555-566. https://doi.org/10.1007/BF01671941
- Hong, K. W., C. G. Kim, S. H. Lee, K. H. Chang, Y. W. Shin, K. H. Ryoo, S. H. Kim, and Y. S. Kim. 2010. A novel anti-EGFR monoclonal antibody inhibiting tumor cell growth by recognizing different epitopes from cetuximab. J. Biotechnol. 145: 84-91. https://doi.org/10.1016/j.jbiotec.2009.09.023
- Yakes, F. M., W. Chinratanalab, C. A. Ritter, W. King, S. Seelig, and C. L. Arteaga. 2002. Herceptin-induced inhibition of phosphatidylinositol-3 kinase and Akt Is required for antibody- mediated effects on p27, cyclin D1, and antitumor action. Cancer Res. 62: 4132-4141.
- Kim, Y. S., R. Bhandari, J. R. Cochran, J. Kuriyan, and K. D. Wittrup. 2006. Directed evolution of the epidermal growth factor receptor extracellular domain for expression in yeast. Proteins. 62: 1026-1035.
- Kim, M. S., S. H. Lee, M. Y. Song, T. H. Yoo, B. K. Lee, and Y. S. Kim. 2007. Comparative analyses of complex formation and binding sites between human tumor necrosis factor- alpha and its three antagonists elucidate their different neutralizing mechanisms. J. Mol. Biol. 374: 1374-1388. https://doi.org/10.1016/j.jmb.2007.10.034
- Song, M. Y., S. K. Park, C. S. Kim, T. H. Yoo, B. Kim, M. S. Kim, Y. S. Kim, W. J. Kwag, B. K. Lee, and K. Baek. 2008. Characterization of a novel anti-human TNF-alpha murine monoclonal antibody with high binding affinity and neutralizing activity. Exp. Mol. Med. 40: 35-42. https://doi.org/10.3858/emm.2008.40.1.35
- Cochran, J. R., Y. S. Kim, M. J. Olsen, R. Bhandari, and K. D. Wittrup. 2004. Domain-level antibody epitope mapping through yeast surface display of epidermal growth factor receptor fragments. J. Immunol. Methods. 287: 147-158. https://doi.org/10.1016/j.jim.2004.01.024
- Burgess, A. W. 2008. EGFR family: structure physiology signalling and therapeutic targets. Growth Factors. 26: 263-274. https://doi.org/10.1080/08977190802312844
- Chothia, C., and A. M. Lesk. 1987. Canonical structures for the hypervariable regions of immunoglobulins. J. Mol. Biol.196: 901-917. https://doi.org/10.1016/0022-2836(87)90412-8
- Li, S., K. R. Schmitz, P. D. Jeffrey, J. J. Wiltzius, P. Kussie, and K. M. Ferguson. 2005. Structural basis for inhibition of the epidermal growth factor receptor by cetuximab. CancerCell. 7: 301-311.
- Adams, G. P., R. Schier, A. M. McCall, H. H. Simmons, E. M. Horak, R. K. Alpaugh, J. D. Marks, and L. M. Weiner. 2001. High affinity restricts the localization and tumor penetration of single-chain fv antibody molecules. Cancer Res. 61:4750-4755.
- Rudnick, S. I., J. Lou, C. C. Shaller, Y. Tang, A. J. Klein-Szanto, L. M. Weiner, J. D. Marks, and G. P. Adams. 2011. Influence of affinity and antigen internalization on the uptake and penetration of Anti-HER2 antibodies in solid tumors. Cancer Res. 71: 2250-2259. https://doi.org/10.1158/0008-5472.CAN-10-2277
- Kamat, V., J. M. Donaldson, C. Kari, M. R. Quadros, P. I. Lelkes, I. Chaiken, S. Cocklin, J. C. Williams, E. Papazoglou, and U. Rodeck. 2008. Enhanced EGFR inhibition and distinct epitope recognition by EGFR antagonistic mAbs C225 and 425. Cancer Biol. Ther. 7: 726-733. https://doi.org/10.4161/cbt.7.5.6097
- Schmiedel, J., A. Blaukat, S. Li, T. Knöchel, and K. M. Ferguson. 2008. Matuzumab binding to EGFR prevents the conformational rearrangement required for dimerization. Cancer Cell. 13: 365-373. https://doi.org/10.1016/j.ccr.2008.02.019
- Li, S., P. Kussie, and K. M. Ferguson. 2008. Structural basis for EGF receptor inhibition by the therapeutic antibody IMC-11F8. Structure 16: 216-227. https://doi.org/10.1016/j.str.2007.11.009
피인용 문헌
- Isolation and Characterisation of a Recombinant Antibody Fragment That Binds NCAM1-Expressing Intervertebral Disc Cells vol.8, pp.12, 2013, https://doi.org/10.1371/journal.pone.0083678
- GC1118, an Anti-EGFR Antibody with a Distinct Binding Epitope and Superior Inhibitory Activity against High-Affinity EGFR Ligands vol.15, pp.2, 2016, https://doi.org/10.1158/1535-7163.mct-15-0679
- Epidermal growth factor receptor (EGFR) involvement in epithelial‐derived cancers and its current antibody‐based immunotherapies vol.44, pp.6, 2012, https://doi.org/10.1002/cbin.11340